Fasenra (benralizumab)

• Severe asthma: adults and children 6 years and older with severe asthma that is the eosinophilic type (linked to high levels of eosinophils); used as an add-on maintenance treatment (taken along with your other daily medicines), not for sudden breathing problems.
• Eosinophilic granulomatosis with polyangiitis (EGPA): adults with EGPA (a rare disease that causes swelling of blood vessels and high eosinophil levels).
• Hypereosinophilic syndrome (HES): adults and children 12 years and older with HES (very high eosinophil levels that can harm organs) when no other cause outside the blood has been found.

A prescription is required. Your prescriber decides whether Fasenra is right for you.

Injection under the skin, given by a healthcare professional, or you or a caregiver after training. A nurse can show you or a caregiver how to give it.

Storage: Keep it in the refrigerator in the original carton to protect it from light; do not freeze or shake it. If needed, it can stay at room temperature (up to 77°F) in the carton for up to 14 days.

Before the first dose, your prescriber may ask for:

• treatment first of any worm (helminth) infection you already have

Read the Medication Guide and the full Fasenra prescribing information, and ask your prescriber or our pharmacists about side effects. Our pharmacists are on call 24 hours a day.

Health plans often require prior authorization for Fasenra. Our intake team checks your coverage and works with your prescriber’s office on the paperwork before your first delivery.

The manufacturer runs a support program, Fasenra 360, that may help eligible patients with costs and access.

Offices can call (844) 671-2600 or fax a referral to (844) 671-2601. Use the Allergy and Asthma Referral Form (PDF).

The manufacturer also publishes Fasenra Access 360 enrollment form.